Mississippi
Mississippi legislators have reintroduced legislation to stop drug companies from denying 340B covered entities access to the manufacturers’ products if the entity uses contract pharmacies.

Mississippi Reintroduces Bill to Ban Drug Makers’ 340B Contract Pharmacy Restrictions

Mississippi legislators have reintroduced legislation to stop drug manufactures from denying 340B covered entities access to the manufacturers’ products if the entity uses contract pharmacies.

Mississippi joins Missouri in making a second attempt to pass legislation modeled after the first-ever Arkansas contract pharmacy law that was passed in 2021. 

Mississippi legislators have reintroduced legislation to stop drug manufactures from denying 340B covered entities access to the manufacturers’ products if the entity uses contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer